Large Korean biopharmaceutical companies have released their financial reports for the first quarter, demonstrating mixed performances.Some companies began to recover from the Covid-19’s fallout that has lasted for more than a year, while others remained in the doldrum for various reasons.Samsung Bi
Korean pharmaceutical companies are rushing to enter the pet treatment market, focusing R&D particularly on diseases like diabetes and cognitive impairment from which old pets tend to suffer.In 2019, 5.9 million Korean households, or 26.4 percent of the total, raised a pet. Industry officials said t
Local pharmaceutical companies are expediting the development of antidepressants as more people suffer from anxiety and depression amid the coronavirus pandemic.According to a survey by Korea Health Promotion Institute, 40.7 percent of the respondents said they experienced anxiety and depression bec
AstraZeneca said Monday that the Ministry of Food and Drug Safety has approved Koselugo (ingredient: selumetinib) for treating pediatric patients with neurofibromatosis type 1 (NF1) above three years old.The Korean regulator approved the drug to treat NF1 patients accompanying plexiform neurofibroma
GSK and Vir Biotechnology said Friday that their Covid-19 drug candidate VIR-7831 has received emergency use authorization (EUA) from the U.S. Food and Drug Administration. FDA granted the EUA for the single monoclonal antibody candidate developed by GSK and Vir to treat and prevent mild and moderat
Novartis Korea said Friday that the Ministry of Food and Drug Safety has approved Zolgensma, gene therapy for spinal muscular atrophy (SMA).Hospitals can use the drug to treat SMA Type 1 patients with a double allelic mutation in the SMN1 gene or three or fewer copies of the SMN Type 2 gene.The mini
Novo Nordisk and Sanofi Aventis, the two dominant insulin providers in Korea, have shown mixed sales performances in the first quarter.According to IQVIA, a drug market research company, Novo Nordisk finally surpassed Sanofi in the first three months, as Tresiba and Ryzodeg generated robust sales in
The European Medicines Agency’s (EMA) Committee for Human Medical Products (CHMP) issued a positive scientific opinion on sotrovimab, a Covid-19 treatment candidate developed by GSK and Vir Biotechnology, GSK said.The CHMP’s evaluation involved the use of sotrovimab for adults and adolescents (aged
Humedix said Thursday that its single-shot formulation Humia for osteoarthritis has obtained Conformite Europeenne certification, and the company would speed up marketing the new medicine in global markets.According to the company, osteoarthritis patients have only need to take one Humia shot per si
Hanmi Pharmaceutical’s Amozaltan XQ, the world's first four-ingredient combination drug for hypertension and dyslipidemia, received positive reviews from medical specialists at an online conference hosted by the Korean Society of Hypertension.“More than half of hypertension patients have dyslipidemi
To develop a globally competitive homegrown blockbuster drug, Korean pharmaceutical companies should choose the most prominent pipelines and concentrate on them, experts said.The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) held a press webinar on the pharmaceutical and biot
The U.S. FDA recently approved Janssen’s Rybrevant (ingredient: amivantamab) as the first targeted therapy for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) exon 20 insertion mutations.In Korea, researchers are testing a combination therapy mixing Rybrevant
Daewoong Pharmaceutical said Wednesday that the Indonesian government has promised to provide full support for the Korean drugmaker’s various projects in the Southeast Asian country.Indonesian Minister of Maritime and Investment Affairs Luhut Binsar Pandjaitan and Minister of Health Budi Gunadi Sadi
inno.N will accelerate the research of new anticancer drugs using big data at the National Cancer Center Cancer and Jeonbuk National University Hospital.The company said Wednesday that it plans to use the CONNECT platform, a cancer big data library, to classify target patients, develop biomarkers, s
Biogen is taking a bold step to win U.S. FDA approval for Alzheimer’s treatment candidate aducanumab in June.On Thursday, Biogen announced that its manufacturing facility in Solothurn, Switzerland received a Good Manufacturing Practice (GMP) certification from the Swiss Agency for Therapeutic Produc
Kangstem Biotech, a stem cell therapy provider, plans to develop the world's first stem cell treatment that fundamentally treats atopic dermatitis with a single dose."We received approval for new phase 3 clinical trials for FureStem AD from the Ministry of Food and Drug Safety in May and will start
Bayer’s Xarelto (ingredient: rivaroxaban) has reduced the risk of death of non-valvular atrial fibrillation (NVAF) patients with type 2 diabetes by about 10 percent, as well as their hospitalization caused by bleeding, compared with Warfarin.The company conducted studies from November 2011 to Decemb
Raon Pharma said it would sell the “cheapest hair loss treatment,” heating up price competition in the hair loss prescription drug market.On Monday, Raon Pharma said it would roll out Finaon Tab. 1mg (finasteride). The announcement came 10 months after the launch of Finawin Tab. 1mg (finasteride). B
Janssen Korea said Monday that Cherry Huang has been appointed as its new chief executive officer effective June 1.Huang will double as Janssen's North Asian head by managing its branches in Taiwan and Hong Kong, it said.New CEO Huang, who joined Janssen in 1998, has held various positions in Jansse
Cheong Wa Dae and the ruling Democratic Party of Korea have praised Samsung Biologics' deal with Moderna to manufacture the latter's mRNA Covid-19 in Korea as a huge success.However, experts showed more cautious reactions to the deal and other vaccine-related agreements.Some industry officials and h